Indivior Pharmaceuticals Crushes Q1 2026 Profit Estimates by 43.3%

AlphaStreet Newsdesk powered by AlphaStreet Intelligence INDV|EPS $0.96 vs $0.67 est (+43.3%)|Rev $317.0M|Net Income $89.0M Stock $35.24 (+3.2%) Strong Beat. ...

Ionis Pharmaceuticals, Inc. Q1 2026 Earnings Call Summary

by FeeOnlyNews.com

April 29, 2026

0

Strategic Performance and Market Positioning Performance in Q1 was driven by strong demand for Tryngolza and DAWNZERA, alongside substantial R&D ...

Eton Pharmaceuticals, Inc. Q4 2025 Earnings Call Summary

by FeeOnlyNews.com

March 19, 2026

0

Revenue more than doubled in 2025 following the successful launch of three cornerstone products: Incrolix, Galzyn, and Kinduvi. Management attributes ...

Teva Pharmaceuticals – TEVA: Abschied vom Generika-Geschäft! Was nun?

by FeeOnlyNews.com

February 13, 2026

0

Strategische Neuausrichtung! Pullback-Setup bei der Teva-Aktie! Kommt der Bounce nach 7 roten Kerzen? Quartalszahlen erst im Mai! Teva Pharmaceuticals (TEVA) ...